ATE5509T1 - Vom serum stammendes ''leukorecruitin'': protein als entzuendungsvermittler aus einem serum von saeugetieren fuer eine spezielle induzierung einer leukozyten-reaktion, prozess fuer deren biotechnische herstellung und isolation in molekular homogener, kristallisierbarer und biologisch spezifischer aktiver form und leukorecruitin enthaltende pharmazeutische zusammensetzungen. - Google Patents
Vom serum stammendes ''leukorecruitin'': protein als entzuendungsvermittler aus einem serum von saeugetieren fuer eine spezielle induzierung einer leukozyten-reaktion, prozess fuer deren biotechnische herstellung und isolation in molekular homogener, kristallisierbarer und biologisch spezifischer aktiver form und leukorecruitin enthaltende pharmazeutische zusammensetzungen.Info
- Publication number
- ATE5509T1 ATE5509T1 AT81107103T AT81107103T ATE5509T1 AT E5509 T1 ATE5509 T1 AT E5509T1 AT 81107103 T AT81107103 T AT 81107103T AT 81107103 T AT81107103 T AT 81107103T AT E5509 T1 ATE5509 T1 AT E5509T1
- Authority
- AT
- Austria
- Prior art keywords
- serum
- leukorecruitin
- protein
- isolation
- derived
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/829—Blood
- Y10S530/83—Plasma; serum
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3034529A DE3034529C2 (de) | 1980-09-12 | 1980-09-12 | Leukorekrutin: Ein Entzündungsmediatorprotein aus Säugerserum zur Induzierung einer Leukozytosereaktion, Herstellungsverfahren, Gewinnung in molekular einheitlicher, kristallisierbarer und biologisch spezifisch wirkender Form und Leukorekrutin enthaltendes Arzneimittel |
EP81107103A EP0047979B1 (de) | 1980-09-12 | 1981-09-09 | Vom Serum stammendes "Leukorecruitin": Protein als Entzündungsvermittler aus einem Serum von Säugetieren für eine spezielle Induzierung einer Leukozyten-Reaktion, Prozess für deren biotechnische Herstellung und Isolation in molekular homogener, kristallisierbarer und biologisch spezifischer aktiver Form und Leukorecruitin enthaltende pharmazeutische Zusammensetzungen |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE5509T1 true ATE5509T1 (de) | 1983-12-15 |
Family
ID=6111831
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT81107103T ATE5509T1 (de) | 1980-09-12 | 1981-09-09 | Vom serum stammendes ''leukorecruitin'': protein als entzuendungsvermittler aus einem serum von saeugetieren fuer eine spezielle induzierung einer leukozyten-reaktion, prozess fuer deren biotechnische herstellung und isolation in molekular homogener, kristallisierbarer und biologisch spezifischer aktiver form und leukorecruitin enthaltende pharmazeutische zusammensetzungen. |
Country Status (9)
Country | Link |
---|---|
US (2) | US4452735A (de) |
EP (1) | EP0047979B1 (de) |
JP (1) | JPS5781414A (de) |
AT (1) | ATE5509T1 (de) |
AU (1) | AU550370B2 (de) |
CA (1) | CA1168981A (de) |
DE (2) | DE3034529C2 (de) |
IL (1) | IL63729A (de) |
ZA (1) | ZA816017B (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5484885A (en) * | 1989-07-05 | 1996-01-16 | Emory University | Chemotactic, antibiotic and lipopolysaccharide-binding peptide fragments of CAP37 |
TW200821026A (en) * | 2006-09-08 | 2008-05-16 | Wyeth Corp | Arginine wash in protein purification using affinity chromatography |
-
1980
- 1980-09-12 DE DE3034529A patent/DE3034529C2/de not_active Expired
-
1981
- 1981-08-26 AU AU74656/81A patent/AU550370B2/en not_active Ceased
- 1981-08-31 ZA ZA816017A patent/ZA816017B/xx unknown
- 1981-09-03 IL IL63729A patent/IL63729A/xx unknown
- 1981-09-09 AT AT81107103T patent/ATE5509T1/de not_active IP Right Cessation
- 1981-09-09 DE DE8181107103T patent/DE3161599D1/de not_active Expired
- 1981-09-09 EP EP81107103A patent/EP0047979B1/de not_active Expired
- 1981-09-10 US US06/300,923 patent/US4452735A/en not_active Expired - Fee Related
- 1981-09-11 CA CA000385708A patent/CA1168981A/en not_active Expired
- 1981-09-11 JP JP56143720A patent/JPS5781414A/ja active Pending
-
1984
- 1984-04-12 US US06/599,534 patent/US4552761A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US4452735A (en) | 1984-06-05 |
DE3034529C2 (de) | 1982-09-23 |
DE3161599D1 (en) | 1984-01-12 |
EP0047979B1 (de) | 1983-12-07 |
IL63729A0 (en) | 1981-12-31 |
US4552761A (en) | 1985-11-12 |
IL63729A (en) | 1984-07-31 |
AU550370B2 (en) | 1986-03-20 |
JPS5781414A (en) | 1982-05-21 |
AU7465681A (en) | 1982-03-18 |
CA1168981A (en) | 1984-06-12 |
EP0047979A1 (de) | 1982-03-24 |
ZA816017B (en) | 1982-08-25 |
DE3034529A1 (de) | 1982-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Klebe | Isolation of a collagen-dependent cell attachment factor | |
Temple et al. | Differentiation of a bipotential glial progenitor cell in single cell microculture | |
Seegers et al. | Inhibition of autoprothrombin C activity with plasma | |
Hovi et al. | Stimulation of chicken lymphocytes by T-and B-cell mitogens | |
JPS5970620A (ja) | 均質なヒトインタ−ロイキン2及びその製造方法 | |
EP0061141B1 (de) | Chemokinesine und Chemotaxine aus Leukozyten und entzündeten Geweben: natürliche Mediationsproteine für umkehrbare Förderung von willkürlichen und gerichteten Bewegungen (Chemokinesis und Chemotaxis) und für Akkumulation von spezifischen Leukozytarten; Verfahren zu ihrer biotechnischen Herstellung und pharmazeutische Zusammensetzungen | |
Chow et al. | Effect of protein depletion on plasma proteins in the dog measured by electrophoretic analysis | |
ATE5509T1 (de) | Vom serum stammendes ''leukorecruitin'': protein als entzuendungsvermittler aus einem serum von saeugetieren fuer eine spezielle induzierung einer leukozyten-reaktion, prozess fuer deren biotechnische herstellung und isolation in molekular homogener, kristallisierbarer und biologisch spezifischer aktiver form und leukorecruitin enthaltende pharmazeutische zusammensetzungen. | |
US4376071A (en) | Mitogenic spinal cord growth factor | |
Calton et al. | Partial purification of Chironex fleckeri (sea wasp) venom by immunochromatography with antivenom | |
EP0292663A1 (de) | Verfahren zur Herstellung von Vitronectin | |
JPS5849319A (ja) | マイトジエンおよびその単離方法 | |
Sugane et al. | Biosynthetic labelling of the excretory and secretory antigens of Toxocara canis larvae | |
DE3737703A1 (de) | Neutrophilen aktivierendes polypeptid, verfahren zu dessen herstellung sowie dessen verwendung als arzneimittel und diagnostikum | |
DE69029040T2 (de) | Megakaryocytopoietischer faktor | |
Ito et al. | Reversible inhibition by human serum lipoproteins of cell proliferation | |
Cottier et al. | Regeneration, Hyperplasie und Onkogenese der lymphoretikulären Organe | |
HASHIMOTO et al. | Presence of connectin-like protein in white blood cells and platelets | |
Chubb | Application of Paper Chromatography to Avian Pathology: 1. The Free Amino Acids in the Blood, Urine and Body Tissues of the Normal Fowl | |
Aleporou-Marinou et al. | Purification of apolipoprotein H (beta2-glycoprotein I)-like protein from human follicular fluid | |
ATE9906T1 (de) | Verfahren zum herstellen und erhalten von anaphylatoxin und cocytotaxin enthaltenden leukotaxin-praeparaten und von anaphylatoxinund cocytotaxin-proteinen in einer molekular homogenen und biologisch aktiven form. | |
Cote et al. | Evaluation of plasma alpha-2-macroglobulin and interactions with tumour necrosis factor-alpha in horses with endotoxemic signs. | |
Kim et al. | Regulation of IgE receptor expression on human peripheral blood lymphocytes by lymphocytosis promoting factor (LPF), lectins and dexamethasone. | |
Havemann et al. | Phytohemagglutinin (PHA) and serum proteins in lymphocyte culture: II. Die Präcipitation von Serumproteinen durch PHA | |
Sauerwein et al. | Induction of proliferation of B prolymphocytic leukemia cells by phorbol ester and native or recombinant interferon-gamma |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |